跳至主要内容
临床试验/CTRI/2025/02/080897
CTRI/2025/02/080897招募中2/3 期

To study the efficacy of Varasanadi kashaya in comparison with Guduchibadhramustadi kashaya in Dyslipidemia: A controlled randomized clinical study

Dr Deepika S1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年3月1日

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Improvement in the lipid profile.

研究概览

简要总结

A Controlled Clinical Study on the Efficacy of Varasanadi Kashaya in the Management of Dyslipidemia in adults of age group of 20-60 years for a period of 30days. During this study period, 30 subjects diagnosed with Dyslipidemia will be recruited and divided into two groups, Group A (Trial drug/Intervention group) and Group B (Control drug/Comparator group), 15 subjects in each group respectively. Group A (Trial drug/Intervention group) it includes 15 subjects qualifying inclusion criteria of the current study will be administered Varasanadi Kashaya (50ml BID Before food) for 30days starting from day-01 of trial, assessment of the patient during trial on 0th day(baseline), 30th day and after trial on 45th day. Group B (Control Drug/Comparator Group) it includes 15 subjects qualifying inclusion criteria of the current study will be administered Guduchibadhramustadi Kashaya (50ml BID Before food) for 30days starting from day-01 of trial, assessment of the patient during trial on 0th day(baseline), 30th day and after trial on 45th day. Clinical assessment will be done for both subjective and objective criteria on 0th day, 30th day and after trial 45th day. Statistical analysis will be done through data obtained on before and after treatment assessment.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Subjects with age group of 20-60 years of either sex irrespective of religion will be selected.
  • 2.Subjects fulfilling all or at least any one of the diagnostic criteria.
  • 3.Fresh cases and patients on medication of dyslipidemia maintaining the manufacturer and batch compulsorily with persisting signs and symptoms and altered quality of life.

排除标准

  • 1.Subjects belonging to the age group of below 20 and above 60 years.
  • 2.Subjects suffering from Chronic systemic illness like Type 1 DM, uncontrolled Type 2 DM, uncontrolled Hypertension.
  • 3.Pregnant and lactating women.
  • 4.Subjects under corticosteroid medications.
  • 5.Subjects having history of myocardial infarction, stroke.
  • 6.Subjects suffering from pancreatitis, thyroid dysfunction.

结局指标

主要结局

Improvement in the lipid profile.

时间窗: 0th day(Baseline), 30th day and 45th day

次要结局

  • Improvement in the lakshana of Medo roga.(0th day(Baseline), 30th day and 45th day)

研究者

发起方
Dr Deepika S
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Deepika S

Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Bengaluru.

研究点 (1)

Loading locations...

相似试验